Hint mode is switched on Switch off

Janux Therapeutics, ordinary share
JANX, US47103J1051

Add a stock to WL
Choose all Reset all
Janux Therapeutics, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Janux Therapeutics, Inc. operates as a biotech company. The Company offers immunotherapies for cancer patients that direct their immune system to eradicate tumors to overcome their diseases as well as provides testing services. Janux Therapeutics serves ...
Janux Therapeutics, Inc. operates as a biotech company. The Company offers immunotherapies for cancer patients that direct their immune system to eradicate tumors to overcome their diseases as well as provides testing services. Janux Therapeutics serves customers worldwide.
Show more Hide
  • Issuer
  • Full borrower / issuer name
    Janux Therapeutics, Inc.
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    JANX
  • Placement
    11.06.2021
  • Lock up period
    180
  • Number of papers
    11,400,000
  • Volume of raised funds
    193.8 mln USD
  • Placement share
    28.57%
  • Final placement price
    17 USD
  • Price change since placement date
    -100%
  • By capitalization
    678.33 mln USD
Other placements of the issuer
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    JANX
  • Placement
    18.07.2023
  • Lock up period
    180
  • Number of papers
    45,987,032
  • Volume of raised funds
    51.76 mln USD
  • Placement share
    9.03%
  • Final placement price
    12.46 USD
  • Price change since placement date
    23.27%
  • By capitalization
    573 mln USD

IFRS/US GAAP reports

2026
I q eng
2025
I q eng
III q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
II q eng
III q eng
IV q eng
Show all Hide

Related Stock indices

Indicators

News

23/06/2026 Janux Therapeutics: Other Events
21/01/2026 Janux Therapeutics: Entry Into Material Definitive Agreement, Regulation Fd Disclosure, Financial Statements And Exhibits
18/09/2025 Janux Therapeutics: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers
11/06/2025 Janux Therapeutics: Submission Of Matters To A Vote Of Security Holders
27/02/2025 Janux Therapeutics: Results Of Operations And Financial Condition, Financial Statements And Exhibits
All organization news

Holders

Industry Leaders

Registration is required to get access.